ArticleTranslational psychiatry2025
A study on electroretinography as a biomarker for seasonal vulnerability in depression.
Article in Translational psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Depressive disorders involve disruptions in light signal processing. Seasonal Affective Disorder (SAD) has been linked to abnormalities in phototransduction, including impaired retinal responses and sleep disturbances. Similar retinal anomalies have been observed in Major Depressive Episode (MDE) patients without seasonal pattern. However, no study has directly compared light-signaling biomarkers between SAD and non-seasonal MDE using sleep assessments and electroretinography (ERG) measures. This study aims to develop a model combining clinical and ERG markers to predict seasonality in MDE patients. Patients with MDE (N = 320) were classified based on their vulnerability to seasonality using the Global Seasonality Score (GSS) from the Seasonal Pattern Assessment Questionnaire (SPAQ), with a threshold of ≥ 11 indicating seasonal vulnerability. This dimensional approach provides a more nuanced reflection of underlying pathophysiological mechanisms than the categorical DSM-5-TR classification of SAD. Subjective sleep, psychiatric, and ERG biomarkers were analyzed. Significant variables were entered into a Backward Stepwise Logistic Regression (N = 35, subset of participants who had all available data including ERG measures), and model performance was assessed using sensitivity, specificity, accuracy, AUC, ROC curve, and Youden's index. The model retained six predictors: reduced bipolar cell amplitude (rods), increased cone response amplitude at 7 cd·s⁻¹·m⁻², increased daytime sleepiness, higher depression severity, younger age, and female gender. It demonstrated good discriminative power (AUC = 0.861, sensitivity = 0.905, specificity = 0.714, Youden's index = 0.619). The model effectively distinguishes seasonal from non-seasonal MDE, explaining 30.5% of the variance. ERG is a promising tool for identifying biomarkers of Seasonal Vulnerability in depression. Enhancing predictive approaches with multimodal diagnostic and longitudinal data could further improve early detection and personalized interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.